Furthermore, genetic ablation of eIF4A in TNBC cells resulted in a decrease in breast cancer stemness (reduced expression of SOX2, OCT4, and NANOG levels) mirroring the level of eIF4A. This evidence concerns the gene SOX2 and breast carcinoma.